Fund shareholders of CG oncology Inc
ISIN US1569441009 · United States
- Fund shareholders
- 306
- Of which ETFs
- 55 251 other funds
- Value held
- 2.2B $ 19.8K € · 13.3M SEK
- Share of capital
- 37.8 % of 88.6M shares on Aug 5, 2026
306 funds hold this company. This table lists the 305 that declare it in a regulatory filing. 1 more fund publishes its holdings in its own report. It is not in the table.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD HEALTH CARE FUND VANGUARD SPECIALIZED FUNDS | 2,589,248 | 172.8M $ | 0.47 % | 2.92 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Capital Appreciation Fund T. ROWE PRICE CAPITAL APPRECIATION FUND, INC. | 2,574,868 | 174.3M $ | 0.26 % | 2.90 % | as of Mar 31, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 2,194,218 | 148.5M $ | 0.01 % | 2.48 % | as of Mar 31, 2026 ↗ |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 1,580,911 | 107M $ | 0.07 % | 1.78 % | as of Mar 31, 2026 ↗ |
| iShares Russell 2000 ETF iShares Trust | 1,443,706 | 97.7M $ | 0.14 % | 1.63 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 1,276,920 | 86.4M $ | 1.16 % | 1.44 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 1,108,573 | 75M $ | 0.69 % | 1.25 % | as of Mar 31, 2026 ↗ |
| VANGUARD SMALL-CAP VALUE INDEX FUND VANGUARD INDEX FUNDS | 1,006,763 | 68.1M $ | 0.11 % | 1.14 % | as of Mar 31, 2026 ↗ |
| Select Health Care Portfolio Fidelity Select Portfolios | 800,000 | 47M $ | 0.76 % | 0.90 % | as of Feb 28, 2026 ↗ |
| Fidelity Small Cap Growth Fund Fidelity Securities Fund | 797,441 | 53.2M $ | 0.63 % | 0.90 % | as of Apr 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 764,799 | 51.8M $ | 0.06 % | 0.86 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Mid-Cap Growth Fund, Inc. T. ROWE PRICE MID-CAP GROWTH FUND, INC. | 745,295 | 50.4M $ | 0.22 % | 0.84 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC. | 742,328 | 50.2M $ | 0.39 % | 0.84 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC. | 631,781 | 42.8M $ | 0.52 % | 0.71 % | as of Mar 31, 2026 ↗ |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 584,836 | 39M $ | 0.12 % | 0.66 % | as of Apr 30, 2026 ↗ |
| JNL/T. Rowe Price Capital Appreciation Fund JNL Series Trust | 569,851 | 38.6M $ | 0.28 % | 0.64 % | as of Mar 31, 2026 ↗ |
| iShares Russell 2000 Growth ETF iShares Trust | 483,212 | 32.7M $ | 0.27 % | 0.55 % | as of Mar 31, 2026 ↗ |
| Fidelity Small Cap Growth K6 Fund Fidelity Securities Fund | 480,339 | 32.1M $ | 0.75 % | 0.54 % | as of Apr 30, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 379,295 | 25.7M $ | 0.32 % | 0.43 % | as of Mar 31, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 366,397 | 24.8M $ | 1.56 % | 0.41 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 357,862 | 21M $ | 0.05 % | 0.40 % | as of Feb 28, 2026 ↗ |
| Strategic Advisers Fidelity U.S. Total Stock Fund Fidelity Rutland Square Trust II | 345,830 | 20.3M $ | 0.01 % | 0.39 % | as of Feb 28, 2026 ↗ |
| Schwab U.S. Small-Cap ETF SCHWAB STRATEGIC TRUST | 332,436 | 19.5M $ | 0.09 % | 0.38 % | as of Feb 28, 2026 ↗ |
| AB Small Cap Growth Portfolio AB CAP FUND, INC. | 314,484 | 21M $ | 0.72 % | 0.35 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Small-Cap Stock Fund, Inc. T. ROWE PRICE SMALL-CAP STOCK FUND, INC. | 305,124 | 20.7M $ | 0.26 % | 0.34 % | as of Mar 31, 2026 ↗ |
| Small Cap Growth Fund American Century Mutual Funds, Inc. | 290,762 | 19.4M $ | 0.38 % | 0.33 % | as of Apr 30, 2026 ↗ |
| Fidelity Advisor Health Care Fund Fidelity Advisor Series VII | 280,000 | 18.7M $ | 0.65 % | 0.32 % | as of Apr 30, 2026 ↗ |
| VANGUARD RUSSELL 2000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 276,818 | 16.3M $ | 0.11 % | 0.31 % | as of Feb 28, 2026 ↗ |
| AB DISCOVERY GROWTH FUND, INC. AB DISCOVERY GROWTH FUND, INC. | 266,728 | 17.8M $ | 0.66 % | 0.30 % | as of Apr 30, 2026 ↗ |
| VANGUARD EXPLORER FUND VANGUARD EXPLORER FUND | 257,600 | 17.2M $ | 0.08 % | 0.29 % | as of Apr 30, 2026 ↗ |
| VY(R) T. ROWE PRICE CAPITAL APPRECIATION PORTFOLIO Voya Investors Trust | 255,838 | 17.3M $ | 0.26 % | 0.29 % | as of Mar 31, 2026 ↗ |
| ClearBridge Small Cap Growth Fund Legg Mason Partners Investment Trust | 245,229 | 16.4M $ | 0.82 % | 0.28 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Capital Appreciation Equity ETF T. Rowe Price Exchange-Traded Funds, Inc. | 240,618 | 16.3M $ | 0.26 % | 0.27 % | as of Mar 31, 2026 ↗ |
| LORD ABBETT DEVELOPING GROWTH FUND INC LORD ABBETT DEVELOPING GROWTH FUND, INC. | 204,698 | 13.7M $ | 0.62 % | 0.23 % | as of Apr 30, 2026 ↗ |
| Franklin Small Cap Growth Fund Franklin Strategic Series | 202,961 | 13.5M $ | 0.55 % | 0.23 % | as of Apr 30, 2026 ↗ |
| Franklin Small-Mid Cap Growth Fund Franklin Strategic Series | 200,480 | 13.4M $ | 0.38 % | 0.23 % | as of Apr 30, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 188,240 | 12.6M $ | 1.21 % | 0.21 % | as of Apr 30, 2026 ↗ |
| Penn Series Flexibly Managed Fund Penn Series Funds Inc | 181,542 | 12.3M $ | 0.26 % | 0.20 % | as of Mar 31, 2026 ↗ |
| Driehaus Small Cap Growth Fund Driehaus Mutual Funds | 176,920 | 12M $ | 1.04 % | 0.20 % | as of Mar 31, 2026 ↗ |
| Putnam Small Cap Growth Fund Putnam Funds Trust | 172,481 | 11.7M $ | 0.43 % | 0.19 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Institutional Small-Cap Stock Fund T. Rowe Price Equity Funds, Inc. | 166,519 | 11.3M $ | 0.26 % | 0.19 % | as of Mar 31, 2026 ↗ |
| PGIM Jennison Small Company Fund Prudential Jennison Small Co Fund, Inc. | 158,834 | 10.7M $ | 0.34 % | 0.18 % | as of Mar 31, 2026 ↗ |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 157,700 | 10.5M $ | 0.55 % | 0.18 % | as of Apr 30, 2026 ↗ |
| First Trust US Equity Opportunities ETF First Trust Exchange-Traded Fund | 147,742 | 10M $ | 0.86 % | 0.17 % | as of Mar 31, 2026 ↗ |
| U.S. MICRO CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 140,271 | 9.4M $ | 0.13 % | 0.16 % | as of Apr 30, 2026 ↗ |
| JNL/T. Rowe Price Mid-Cap Growth Fund JNL Series Trust | 132,293 | 9M $ | 0.22 % | 0.15 % | as of Mar 31, 2026 ↗ |
| Schwab Small-Cap Index Fund SCHWAB CAPITAL TRUST | 129,479 | 8.6M $ | 0.12 % | 0.15 % | as of Apr 30, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 129,358 | 7.6M $ | 0.01 % | 0.15 % | as of Feb 28, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 128,733 | 7.6M $ | 0.04 % | 0.15 % | as of Feb 28, 2026 ↗ |
| Fidelity Small Cap Discovery Fund Fidelity Concord Street Trust | 128,600 | 8.6M $ | 0.39 % | 0.15 % | as of Apr 30, 2026 ↗ |
| Fidelity U.S. Equity Central Fund Fidelity Central Investment Portfolios LLC | 128,000 | 8.7M $ | 0.04 % | 0.14 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Small-Cap Value Fund, Inc. T. ROWE PRICE SMALL-CAP VALUE FUND, INC. | 127,292 | 8.6M $ | 0.09 % | 0.14 % | as of Mar 31, 2026 ↗ |
| AST Small-Cap Equity Portfolio Advanced Series Trust | 118,184 | 8M $ | 0.43 % | 0.13 % | as of Mar 31, 2026 ↗ |
| EQ/AB Small Cap Growth Portfolio EQ Advisors Trust | 114,925 | 7.8M $ | 0.41 % | 0.13 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Small Cap Discovery Fund Fidelity Concord Street Trust | 114,600 | 7.6M $ | 0.39 % | 0.13 % | as of Apr 30, 2026 ↗ |
| VIP Health Care Portfolio Variable Insurance Products Fund IV | 105,000 | 7.1M $ | 0.71 % | 0.12 % | as of Mar 31, 2026 ↗ |
| Federated Hermes MDT Small Cap Core Fund Federated Hermes MDT Series | 104,264 | 7M $ | 0.37 % | 0.12 % | as of Apr 30, 2026 ↗ |
| Fidelity Advisor Small Cap Fund Fidelity Advisor Series I | 104,100 | 6.1M $ | 0.28 % | 0.12 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 101,477 | 6M $ | 0.01 % | 0.11 % | as of Feb 28, 2026 ↗ |
| MFS New Discovery Fund MFS SERIES TRUST I | 100,229 | 5.9M $ | 0.28 % | 0.11 % | as of Feb 28, 2026 ↗ |
| Master Small Cap Index Series Quantitative Master Series LLC | 96,101 | 6.5M $ | 0.13 % | 0.11 % | as of Mar 31, 2026 ↗ |
| SmallCap Growth Fund I Principal Funds, Inc | 93,016 | 6.2M $ | 0.26 % | 0.10 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Institutional Mid-Cap Equity Growth Fund T. Rowe Price Equity Funds, Inc. | 90,560 | 6.1M $ | 0.22 % | 0.10 % | as of Mar 31, 2026 ↗ |
| Small Cap Growth Stock Portfolio NORTHWESTERN MUTUAL SERIES FUND INC | 88,203 | 6M $ | 0.81 % | 0.10 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs Small/Mid Cap Growth Fund Goldman Sachs Trust | 87,019 | 5.1M $ | 0.42 % | 0.10 % | as of Feb 28, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 86,512 | 5.9M $ | 0.01 % | 0.10 % | as of Mar 31, 2026 ↗ |
| ClearBridge Small Cap Fund Legg Mason Global Asset Management Trust | 85,900 | 5.7M $ | 0.78 % | 0.10 % | as of Apr 30, 2026 ↗ |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 83,362 | 5.6M $ | 0.04 % | 0.09 % | as of Apr 30, 2026 ↗ |
| T.Rowe Price Small Cap Growth Portfolio Brighthouse Funds Trust II | 81,190 | 5.5M $ | 0.52 % | 0.09 % | as of Mar 31, 2026 ↗ |
| Direxion Daily S&P Biotech Bull 3X Shares Direxion Shares ETF Trust | 73,170 | 4.9M $ | 0.94 % | 0.08 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Small Cap Growth Fund Goldman Sachs Trust | 72,608 | 4.3M $ | 1.01 % | 0.08 % | as of Feb 28, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 71,897 | 4.2M $ | 3.06 % | 0.08 % | as of Feb 28, 2026 ↗ |
| Nuveen Small Cap Blend Index Fund TIAA-CREF Funds | 70,790 | 4.7M $ | 0.12 % | 0.08 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 69,646 | 4.7M $ | 0.71 % | 0.08 % | as of Mar 31, 2026 ↗ |
| MassMutual Mid Cap Growth Fund MASSMUTUAL SELECT FUNDS | 68,390 | 4.6M $ | 0.17 % | 0.08 % | as of Mar 31, 2026 ↗ |
| First Trust Mid Cap Core AlphaDEX Fund First Trust Exchange-Traded AlphaDEX Fund | 67,215 | 4.5M $ | 0.34 % | 0.08 % | as of Apr 30, 2026 ↗ |
| Fidelity Small Cap Value Fund Fidelity Securities Fund | 66,905 | 4.5M $ | 0.09 % | 0.08 % | as of Apr 30, 2026 ↗ |
| Small Cap Core Portfolio Bernstein Fund Inc | 64,690 | 4.4M $ | 0.61 % | 0.07 % | as of Mar 31, 2026 ↗ |
| HARTFORD SMALL CAP GROWTH HLS FUND HARTFORD SERIES FUND INC | 63,521 | 4.3M $ | 0.81 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Empower T. Rowe Price Mid Cap Growth Fund EMPOWER FUNDS, INC. | 62,839 | 4.3M $ | 0.22 % | 0.07 % | as of Mar 31, 2026 ↗ |
| EQ/2000 Managed Volatility Portfolio EQ Advisors Trust | 61,769 | 4.2M $ | 0.12 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Small-Cap Growth Portfolio PACIFIC SELECT FUND | 61,078 | 4.1M $ | 0.94 % | 0.07 % | as of Mar 31, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 59,514 | 3.5M $ | 0.05 % | 0.07 % | as of Feb 27, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 58,331 | 3.9M $ | 0.01 % | 0.07 % | as of Apr 30, 2026 ↗ |
| Tax-Managed U.S. Mid & Small Cap Fund RUSSELL INVESTMENT CO | 56,927 | 3.8M $ | 0.18 % | 0.06 % | as of Apr 30, 2026 ↗ |
| THE HARTFORD SMALL COMPANY FUND HARTFORD MUTUAL FUNDS, INC | 52,274 | 3.5M $ | 0.53 % | 0.06 % | as of Apr 30, 2026 ↗ |
| Column Small Cap Select Fund Trust for Professional Managers | 52,017 | 3.1M $ | 0.18 % | 0.06 % | as of Feb 28, 2026 ↗ |
| VANGUARD RUSSELL 2000 GROWTH INDEX FUND VANGUARD SCOTTSDALE FUNDS | 51,158 | 3M $ | 0.21 % | 0.06 % | as of Feb 28, 2026 ↗ |
| First Trust Mid Cap Growth AlphaDEX Fund First Trust Exchange-Traded AlphaDEX Fund | 50,655 | 3.4M $ | 0.65 % | 0.06 % | as of Apr 30, 2026 ↗ |
| ClearBridge Variable Small Cap Growth Portfolio Legg Mason Partners Variable Equity Trust | 50,200 | 3.4M $ | 0.86 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs Small Cap Value Fund Goldman Sachs Trust | 49,930 | 2.9M $ | 0.31 % | 0.06 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Small-Mid Cap ETF T. Rowe Price Exchange-Traded Funds, Inc. | 49,906 | 3.4M $ | 0.22 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Fidelity Enhanced Small Cap ETF Fidelity Covington Trust | 48,364 | 3.3M $ | 0.08 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Transamerica T. Rowe Price Small Cap VP TRANSAMERICA SERIES TRUST | 48,231 | 3.3M $ | 0.52 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Nuveen Equity Index Fund TIAA-CREF Funds | 47,781 | 3.2M $ | 0.01 % | 0.05 % | as of Apr 30, 2026 ↗ |
| SMALL CAP EQUITY FUND GuideStone Funds | 47,770 | 3.2M $ | 0.39 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 47,160 | 2.8M $ | 0.01 % | 0.05 % | as of Feb 28, 2026 ↗ |
| Federated Hermes MDT Small Cap Growth Fund Federated Hermes MDT Series | 46,181 | 3.1M $ | 0.41 % | 0.05 % | as of Apr 30, 2026 ↗ |
| Tema Oncology ETF Tema ETF Trust | 45,885 | 2.7M $ | 1.69 % | 0.05 % | as of Feb 28, 2026 ↗ |
| Fidelity Small Cap Growth Index Fund Fidelity Salem Street Trust | 44,956 | 3M $ | 0.27 % | 0.05 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 3.06 % | as of Feb 28, 2026 ↗ |
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 2.00 % | as of Sep 30, 2025 ↗ |
| Tema Oncology ETF Tema ETF Trust | 1.69 % | as of Feb 28, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 1.56 % | as of Mar 31, 2026 ↗ |
| Invesco Dorsey Wright Healthcare Momentum ETF Invesco Exchange-Traded Fund Trust | 1.55 % | as of Apr 30, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 1.21 % | as of Apr 30, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 1.21 % | as of Apr 30, 2026 ↗ |
| AMG TimesSquare Small Cap Growth Fund AMG Funds | 1.17 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 1.16 % | as of Mar 31, 2026 ↗ |
| PROFUND VP BIOTECHNOLOGY ProFunds | 1.13 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 303 | +44 | 33,492,521 | +14.9 % |
| 2026Q1 | 259 | +40 | 29,149,569 | +18.3 % |
| 2025Q4 | 219 | +21 | 24,635,869 | +8.0 % |
| 2025Q3 | 198 | +11 | 22,820,507 | +24.3 % |
| 2025Q2 | 187 | +21 | 18,361,596 | +13.2 % |
| 2025Q1 | 166 | +17 | 16,213,904 | +33.7 % |
| 2024Q4 | 149 | +5 | 12,122,737 | +64.5 % |
| 2024Q3 | 144 | +20 | 7,371,109 | +13.8 % |
| 2024Q2 | 124 | +114 | 6,474,994 | +414.8 % |
| 2024Q1 | 10 | 1,257,721 |
Institutional managers
227 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| RTW INVESTMENTS, LP | 6,984,808 | 472.7M $ | as of Mar 31, 2026 |
| T. Rowe Price Investment Management, Inc. | 6,720,389 | 454.8K $ | as of Mar 31, 2026 |
| Decheng Capital LLC | 6,371,669 | 431.2M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 5,371,232 | 363.5M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 5,064,180 | 342.7M $ | as of Mar 31, 2026 |
| FMR LLC | 3,764,844 | 254.8M $ | as of Mar 31, 2026 |
| TCG Crossover Management, LLC | 3,670,206 | 248.4M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3,652,980 | 247.2K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 2,647,054 | 179.2M $ | as of Mar 31, 2026 |
| Foresite Capital Management VI LLC | 2,221,474 | 150.3M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,596,864 | 108.1M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 1,507,005 | 102M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 1,449,364 | 98.1M $ | as of Mar 31, 2026 |
| DV Trading LLC | 1,439,393 | 97.4M $ | as of Mar 31, 2026 |
| UBS Group AG | 1,311,978 | 88.8M $ | as of Mar 31, 2026 |
| ALLIANCEBERNSTEIN L.P. | 1,290,087 | 53.6M $ | as of Mar 31, 2026 |
| Avidity Partners Management LP | 1,288,948 | 87.2M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 1,159,239 | 78.5M $ | as of Mar 31, 2026 |
| ACORN CAPITAL ADVISORS, LLC | 1,130,501 | 76.6M $ | as of Mar 31, 2026 |
| EcoR1 Capital, LLC | 1,102,000 | 74.6M $ | as of Mar 31, 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1,064,966 | 72.1M $ | as of Mar 31, 2026 |
| Foresite Capital Management V, LLC | 1,004,050 | 68M $ | as of Mar 31, 2026 |
| Driehaus Capital Management LLC | 999,623 | 67.7M $ | as of Mar 31, 2026 |
| BRAIDWELL LP | 984,783 | 66.7M $ | as of Mar 31, 2026 |
| ORBIMED ADVISORS LLC | 948,267 | 64.2M $ | as of Mar 31, 2026 |
Declared shareholders of CG oncology Inc
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| RTW Investments, LP and 1 other | 8.30 % | 6,984,808 | as of Mar 31, 2026 · SCHEDULE 13G |
| T. Rowe Price Investment Management, Inc. | 8.00 % | 6,720,389 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of CG oncology Inc". https://titelia.com/en/stocks/cg-oncology-inc-US1569441009